Analysts rate Dexco S.A. Strong Buy (bullish), based on 10 analysts. Average price target: R$8.44.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 639 declarations
Dexco S.A., a Brazilian company valued at BRL 7.51 billion, is 51% held by its insiders, and its record is anonymous: 5 profiles, with 356 filings under Controlador ou Vinculado and 188 under Diretor ou Vinculado.
The 639 filings, published between December 1, 2018 and October 9, 2026, include 391 of another kind, 65 option exercises and 56 grants. Open-market trades are 62 sales, 57 of them with an amount and a median of EUR 268,863, and 65 purchases, 56 of them with an amount and a median of EUR 31,744, or 51% purchases. The largest amounts in the record repeat identically as a purchase and as a sale on the same date, which suggests internal movements recorded in both directions; the sums are therefore not quoted here.
The publication delay is long, a median of 20 days. Yearly volume reaches 173 filings in 2025, against 11 in 2021. Over twelve months: 76 filings, 10 purchases, 9 sales. For 60 purchases the 90-day median is 13.7%, with 67% positive (stored past results, not a forecast).
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: São Paulo, Brazil · Founded: 1951 · Wikipedia article
Source: Wikidata (CC0).